Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection, the Netherlands, September to December 2022

We used data of 32,542 prospective cohort study participants who previously received primary and one or two monovalent booster COVID-19 vaccinations. Between 26 September and 19 December 2022, relative effectiveness of bivalent original/Omicron BA.1 vaccination against self-reported Omicron SARS-CoV...

Descripción completa

Detalles Bibliográficos
Autores principales: Huiberts, Anne J, de Gier, Brechje, Hoeve, Christina E, de Melker, Hester E, Hahné, Susan JM, den Hartog, Gerco, van de Wijgert, Janneke HHM, van den Hof, Susan, Knol, Mirjam J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2023
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936593/
https://www.ncbi.nlm.nih.gov/pubmed/36795500
http://dx.doi.org/10.2807/1560-7917.ES.2023.28.7.2300087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936593/
https://www.ncbi.nlm.nih.gov/pubmed/36795500
http://dx.doi.org/10.2807/1560-7917.ES.2023.28.7.2300087

Ejemplares similares